Drug Controller General of India

Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi.

US FDA Denies Bharat Biotech’s Covaxin Emergency Use Approval

The Wire Staff 11/06/2021

The FDA's verdict is the second roadblock Bharat Biotech...

vg somani

Dr Reddy’s Revealed More About 2-DG, and Its Approval Is More Confusing Now

Ronak Borana 04/06/2021

Several experts to whom The Wire Science reached out...

FILE PHOTO: Vials labelled "Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine" are seen in this illustration picture

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines

The Wire Staff 02/06/2021

Vaccines which have been approved by select regulatory bodies...

253067_363518360394024_1607772251_n

COVID-19: Antibody Cocktail Treatment Begins at Delhi’s Sir Ganga Ram Hospital

The hospital is administering a combination of casirivimab and...

Screenshot 2021-04-06 at 9.03.20 AM

Will Make, Supply 10 Cr Covishield Doses in June: Serum Institute to Centre

In early May, SII had communicated to the Centre...

analuisa-gamboa-WsTP_d3VEgk-unsplash

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

Ronak Borana 25/05/2021

Many COVID-19-related clinical trials have several methodological flaws, and...

KT 18 May 2021.00_44_36_15.Still002

‘B.1.617.2 May Be 50% More Contagious Than Variant First Seen in UK’

Karan Thapar 19/05/2021

Gagandeep Kang said B.1.617.2 is a key component of...